May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients' questions? An evidence-controlled analysis

World J Gastroenterol. 2024 Jan 7;30(1):17-33. doi: 10.3748/wjg.v30.i1.17.

Abstract

Artificial intelligence is increasingly entering everyday healthcare. Large language model (LLM) systems such as Chat Generative Pre-trained Transformer (ChatGPT) have become potentially accessible to everyone, including patients with inflammatory bowel diseases (IBD). However, significant ethical issues and pitfalls exist in innovative LLM tools. The hype generated by such systems may lead to unweighted patient trust in these systems. Therefore, it is necessary to understand whether LLMs (trendy ones, such as ChatGPT) can produce plausible medical information (MI) for patients. This review examined ChatGPT's potential to provide MI regarding questions commonly addressed by patients with IBD to their gastroenterologists. From the review of the outputs provided by ChatGPT, this tool showed some attractive potential while having significant limitations in updating and detailing information and providing inaccurate information in some cases. Further studies and refinement of the ChatGPT, possibly aligning the outputs with the leading medical evidence provided by reliable databases, are needed.

Keywords: Artificial intelligence; Chat Generative Pre-trained Transformer; Crohn’s disease; Inflammatory bowel disease; Large language model; Ulcerative colitis.

Publication types

  • Review

MeSH terms

  • Artificial Intelligence
  • Databases, Factual
  • Gastroenterologists*
  • Humans
  • Inflammatory Bowel Diseases*
  • Language